Journal
AMERICAN JOURNAL OF NEURORADIOLOGY
Volume 32, Issue 8, Pages 1373-1374Publisher
AMER SOC NEURORADIOLOGY
DOI: 10.3174/ajnr.A2619
Keywords
-
Ask authors/readers for more resources
Herceptin (trastuzumab) is a human monoclonal antibody that interferes with the HER2 receptor. It is currently the only FDA-approved therapeutic antibody for HER2-positive breast cancer. This article will present the mechanism at action as well as the clinical role at this monoclonal antibody.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
